{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:58:19Z","timestamp":1792785499242,"version":"4.5.0"},"reference-count":199,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100023969","name":"Hellenic Thoracic Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023969","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union","id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Greek national funds"},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"General Secretariat for Research and Innovation","award":["\u0395\u039a\u03a0\u0391\u03a102-0065854"],"award-info":[{"award-number":["\u0395\u039a\u03a0\u0391\u03a102-0065854"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"DOI":"10.1080\/17425247.2026.2748249","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:57:51Z","timestamp":1791647871000},"page":"1-25","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Inhalation therapies in interstitial lung diseases"],"prefix":"10.1080","author":[{"given":"Stefanos","family":"Smyrniotis","sequence":"first","affiliation":[{"name":"Biomedical Sciences Research Center \u201cAlexander Fleming\u201d","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Tomos","sequence":"additional","affiliation":[{"name":"\u2018Sotiria\u2019 Chest Diseases Hospital of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina M.","family":"Antoniou","sequence":"additional","affiliation":[{"name":"University of Crete","place":["Heraklion, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioulia","family":"Tseti","sequence":"additional","affiliation":[{"name":"Uni-Pharma S.A","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Aidinis","sequence":"additional","affiliation":[{"name":"Biomedical Sciences Research Center \u201cAlexander Fleming\u201d","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.74"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2221PP"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2807"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2277"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1300575"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00017-5"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00009113"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01052-2"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00077309"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00362-2025"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03187-2021"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02718-2020"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-025-00302-5"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402582"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30339-4"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2015-000105"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020655"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2024.2375420"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0053-2017"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001687"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-02929-7"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S87271"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020444330011"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40749-015-0011-0"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2732017"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02407-6"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01653-2015"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70101-8"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00002512"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200602-163OC"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.062836"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00165207"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.149.2.8306044"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40248-019-0197-0"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0062-2017"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0801CI"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-021-00786-z"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00591-2021"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.3-b.s17"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1205948"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88734-2"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02163-2022"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.1.284"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.12.009"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573398X11666150619182624"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204202"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.047"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.17509540"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0608"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00585-2022"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0125-2019"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2017-000207"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A3204"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.400"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1530697"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1177\/1753465812436663"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200404-571OC"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(16)30326-5"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-1298-1"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-024-03720-7"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.11.035"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-025-03916-2"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.4.9907002"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-93-3-391"},{"issue":"8222","key":"e_1_3_6_71_1","first-page":"681","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the medical research council working party","volume":"1","year":"1981","unstructured":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the medical research council working party. Lancet. 1981;1(8222):681\u2013686. PubMed PMID: 6110912.","journal-title":"Lancet"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1458"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2007.01205.x"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0017-2021"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13610"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1997.83.4.1192"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0732-0"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2011.0916"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0245-x"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics18010108"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202502624R"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01971-7"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2153"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.100966"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2007.09.005"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01892.x"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2023.100167"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2022.107094"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160128145356"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics18020168"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2020.1702643"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/cryst11121440"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9537-8"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.07.041"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122706"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.03.017"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.4.1069"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2021.1854222"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.11.002"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00173"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028241"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123987"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202404-0683ED"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.07.015"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c11147"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-015-1701-7"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115147"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2014.05.017"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15045852"},{"issue":"7","key":"e_1_3_6_110_1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.21037\/atm-20-3946","article-title":"Administration of dry powders during respiratory supports","volume":"9","author":"Ke WR","year":"2021","unstructured":"Ke WR, Chang RYK, Kwok PCL, et al. Administration of dry powders during respiratory supports. Ann Transl Med. 2021;9(7):596. PubMed PMID: 33987294.","journal-title":"Ann Transl Med"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01893.x"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00220001"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10020037"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2017-0102"},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.984683"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1389-9"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2023.2231850"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S4937"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106509"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16111391"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2025.31.1-a.s2"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008470"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030934"},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2018.1507"},{"key":"e_1_3_6_125_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219391"},{"key":"e_1_3_6_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.01.017"},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121432"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2011.0919"},{"issue":"2","key":"e_1_3_6_129_1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/jamp.2019.1552","article-title":"Maximizing deep lung deposition in healthy and fibrotic subjects during jet nebulization","volume":"33","author":"Samuel J","year":"2020","unstructured":"Samuel J, Smaldone GC. Maximizing deep lung deposition in healthy and fibrotic subjects during jet nebulization. J Aerosol Med Pulm Drug Deliv. 2020;33(2):108\u2013115. PubMed PMID: 31855492.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"e_1_3_6_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328349ac2b"},{"key":"e_1_3_6_131_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring animal models that resemble idiopathic pulmonary fibrosis","volume":"4","author":"Tashiro J","year":"2017","unstructured":"Tashiro J, Rubio GA, Limper AH, et al. Exploring animal models that resemble idiopathic pulmonary fibrosis. Front Med (Lausanne). 2017;4:118. PubMed PMID: 28804709.","journal-title":"Front Med (Lausanne)"},{"key":"e_1_3_6_132_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fmed.2018.00269","article-title":"Bleomycin revisited: a direct comparison of the intratracheal micro-spraying and the oropharyngeal aspiration routes of bleomycin administration in mice","volume":"5","author":"Barbayianni I","year":"2018","unstructured":"Barbayianni I, Ninou I, Tzouvelekis A, et al. Bleomycin revisited: a direct comparison of the intratracheal micro-spraying and the oropharyngeal aspiration routes of bleomycin administration in mice. Front Med (Lausanne). 2018;5:269. PubMed PMID: 30320115.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"e_1_3_6_133_1","first-page":"185","article-title":"The pathogenesis of bleomycin-induced pulmonary fibrosis in mice","volume":"77","author":"Adamson IY","year":"1974","unstructured":"Adamson IY, Bowden DH. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol. 1974;77(2):185\u2013197. PubMed PMID: 4141224.","journal-title":"Am J Pathol"},{"key":"e_1_3_6_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2018.02.003"},{"key":"e_1_3_6_135_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2017-0096ST"},{"key":"e_1_3_6_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(23)00325-9"},{"key":"e_1_3_6_137_1","doi-asserted-by":"publisher","DOI":"10.1097\/mcp.0000000000000091"},{"key":"e_1_3_6_138_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2023.0041"},{"key":"e_1_3_6_139_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfab062"},{"key":"e_1_3_6_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105648"},{"key":"e_1_3_6_141_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008466"},{"key":"e_1_3_6_142_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2020.1730807"},{"key":"e_1_3_6_143_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2016.1342"},{"key":"e_1_3_6_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2020.101938"},{"key":"e_1_3_6_145_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fmed.2018.00180","article-title":"Autotaxin in pathophysiology and pulmonary fibrosis","volume":"5","author":"Ninou I","year":"2018","unstructured":"Ninou I, Magkrioti C, Aidinis V. Autotaxin in pathophysiology and pulmonary fibrosis. Front Med (Lausanne). 2018;5:180. PubMed PMID: 29951481.","journal-title":"Front Med (Lausanne)"},{"key":"e_1_3_6_146_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0004OC"},{"key":"e_1_3_6_147_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.12637"},{"key":"e_1_3_6_148_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.5355"},{"key":"e_1_3_6_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102778"},{"issue":"1","key":"e_1_3_6_150_1","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1038\/s41467-025-58568-x","article-title":"Preclinical concept studies showing advantage of an inhaled anti-CTGF\/CCN2 protein for pulmonary fibrosis treatment","volume":"16","author":"Neiens V","year":"2025","unstructured":"Neiens V, Hansbauer EM, Jaquin TJ, et al. Preclinical concept studies showing advantage of an inhaled anti-CTGF\/CCN2 protein for pulmonary fibrosis treatment. Nat Commun. 2025;16(1):3251. PubMed PMID: 40185752.","journal-title":"Nat Commun"},{"key":"e_1_3_6_151_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.8693"},{"key":"e_1_3_6_152_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14344-7"},{"issue":"1","key":"e_1_3_6_153_1","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1038\/s41467-023-41614-x","article-title":"SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosis","volume":"14","author":"Barbayianni I","year":"2023","unstructured":"Barbayianni I, Kanellopoulou P, Fanidis D, et al. SRC and TKS5 mediated podosome formation in fibroblasts promotes extracellular matrix invasion and pulmonary fibrosis. Nat Commun. 2023;14(1):5882. PubMed PMID: 37735172.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_6_154_1","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1038\/s41467-020-18397-6","article-title":"Translational pharmacology of an inhaled small molecule \u03b1v\u03b26 integrin inhibitor for idiopathic pulmonary fibrosis","volume":"11","author":"John AE","year":"2020","unstructured":"John AE, Graves RH, Pun KT, et al. Translational pharmacology of an inhaled small molecule \u03b1v\u03b26 integrin inhibitor for idiopathic pulmonary fibrosis. Nat Commun. 2020;11(1):4659. PubMed PMID: 32938936.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_6_155_1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1186\/s12967-024-05895-0","article-title":"Inhalation of itraconazole mitigates bleomycin-induced lung fibrosis via regulating SPP1 and C3 signaling pathway pivotal in the interaction between phagocytic macrophages and diseased fibroblasts","volume":"22","author":"Pan C","year":"2024","unstructured":"Pan C, Wei H, Chen B, et al. Inhalation of itraconazole mitigates bleomycin-induced lung fibrosis via regulating SPP1 and C3 signaling pathway pivotal in the interaction between phagocytic macrophages and diseased fibroblasts. J Transl Med. 2024;22(1):1058. PubMed PMID: 39587675.","journal-title":"J Transl Med"},{"issue":"25","key":"e_1_3_6_156_1","doi-asserted-by":"crossref","first-page":"eabn7162","DOI":"10.1126\/sciadv.abn7162","article-title":"Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge","volume":"8","author":"Bai X","year":"2022","unstructured":"Bai X, Zhao G, Chen Q, et al. Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge. Sci Adv. 2022;8(25):eabn7162. PubMed PMID: 35731866.","journal-title":"Sci Adv"},{"key":"e_1_3_6_157_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020157"},{"issue":"1","key":"e_1_3_6_158_1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s12951-024-02721-z","article-title":"Nebulized milk exosomes loaded with siTGF-\u03b21 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability","volume":"22","author":"Qiu C","year":"2024","unstructured":"Qiu C, Zhao Z, Xu C, et al. Nebulized milk exosomes loaded with siTGF-\u03b21 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability. J Nanobiotechnol. 2024;22(1):434. PubMed PMID: 39044233.","journal-title":"J Nanobiotechnol"},{"key":"e_1_3_6_159_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2732-2"},{"key":"e_1_3_6_160_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13010031"},{"key":"e_1_3_6_161_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph19020197"},{"key":"e_1_3_6_162_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091528"},{"key":"e_1_3_6_163_1","doi-asserted-by":"crossref","unstructured":"Chaudhuri N Lancaster L Palmer S et al. Late breaking abstract - inhaled pirfenidone (AP01) forced vital capacity (FVC) data from the ATLAS study vs placebo from 3\u00a0historical idiopathic pulmonary fibrosis (IPF) randomised controlled trials (RCTs). 62(suppl 67):A3485. https:\/\/publications.ersnet.org\/content\/erj\/62\/suppl67\/pa3485","DOI":"10.1183\/13993003.congress-2023.PA3485"},{"key":"e_1_3_6_164_1","doi-asserted-by":"crossref","unstructured":"Kim G Goldin J Nair D et al. Association between functional improvement and structural changes in quantitative high-resolution ct in ATLAS: a phase 1b study of inhaled pirfenidone in idiopathic pulmonary fibrosis. 64(suppl 68):A692. https:\/\/publications.ersnet.org\/content\/erj\/64\/suppl68\/pa692","DOI":"10.1183\/13993003.congress-2024.PA692"},{"issue":"68","key":"e_1_3_6_165_1","first-page":"A690","article-title":"Inhalation innovation: phase 2b study design of inhaled pirfenidone in the treatment of progressive pulmonary","volume":"64","author":"Kolb M","unstructured":"Kolb M, Reisner C, Nair D, et al. Inhalation innovation: phase 2b study design of inhaled pirfenidone in the treatment of progressive pulmonary. Fibrosis. 64(suppl 68):A690. https:\/\/publications.ersnet.org\/content\/erj\/64\/suppl68\/pa690","journal-title":"Fibrosis"},{"issue":"2088","key":"e_1_3_6_166_1","article-title":"A double-blind, placebo-controlled, randomized phase 1 study to evaluate safety, tolerability, and pharmacokinetics after single or repeat twice-daily doses of AP02, a nebulized formulation of nintedanib (abstract)","volume":"211","author":"Palacios M","year":"2025","unstructured":"Palacios M, Boone R, Pham S, et al. A double-blind, placebo-controlled, randomized phase 1 study to evaluate safety, tolerability, and pharmacokinetics after single or repeat twice-daily doses of AP02, a nebulized formulation of nintedanib (abstract). Am J Respir Crit Care Med. 2025;211(A2088). https:\/\/academic.oup.com\/ajrccm\/article\/211\/Supplement_1\/A2088\/8335708","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_6_167_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv9571"},{"key":"e_1_3_6_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.01.032"},{"key":"e_1_3_6_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106779"},{"key":"e_1_3_6_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2013.08.004"},{"key":"e_1_3_6_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19294-1"},{"key":"e_1_3_6_172_1","doi-asserted-by":"crossref","first-page":"669227","DOI":"10.3389\/fphar.2021.669227","article-title":"Inhibition of the proliferation of human lung fibroblasts by Prostacyclin receptor agonists is linked to a sustained cAMP signal in the nucleus","volume":"12","author":"Roberts MJ","year":"2021","unstructured":"Roberts MJ, May LT, Keen AC, et al. Inhibition of the proliferation of human lung fibroblasts by Prostacyclin receptor agonists is linked to a sustained cAMP signal in the nucleus. Front Pharmacol. 2021;12:669227. PubMed PMID: 33995100.","journal-title":"Front Pharmacol"},{"key":"e_1_3_6_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(21)00165-x"},{"issue":"3759","key":"e_1_3_6_174_1","article-title":"TETON phase 3 clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis: annual update of preliminary baseline data [abstract]","volume":"209","author":"Nathan SD","year":"2024","unstructured":"Nathan SD, Behr J, Cottin V, et al. TETON phase 3 clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis: annual update of preliminary baseline data [abstract]. Am J Respir Crit Care Med. 2024;209(A3759). https:\/\/academic.oup.com\/ajrccm\/article\/211\/Supplement_1\/A1786\/8335346","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_6_175_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2512911"},{"issue":"1785","key":"e_1_3_6_176_1","article-title":"TETON-PPF clinical trial of inhaled treprostinil for the treatment of progressive pulmonary fibrosis: preliminary baseline demographics [abstract]","volume":"211","author":"Nathan SD","year":"2025","unstructured":"Nathan SD, Behr J, Cottin V, et al. TETON-PPF clinical trial of inhaled treprostinil for the treatment of progressive pulmonary fibrosis: preliminary baseline demographics [abstract]. Am J Respir Crit Care Med. 2025;211(A1785). https:\/\/academic.oup.com\/ajrccm\/article\/211\/Supplement_1\/A1785\/8335348","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_6_177_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12138"},{"key":"e_1_3_6_178_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30310-7"},{"key":"e_1_3_6_179_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202106-1485OC"},{"key":"e_1_3_6_180_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098116"},{"key":"e_1_3_6_181_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511167103"},{"key":"e_1_3_6_182_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201106-0965OC"},{"key":"e_1_3_6_183_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.O-06-449"},{"key":"e_1_3_6_184_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00326.2010"},{"key":"e_1_3_6_185_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02559-2020"},{"key":"e_1_3_6_186_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00170.2010"},{"key":"e_1_3_6_187_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061536"},{"key":"e_1_3_6_188_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001520107"},{"key":"e_1_3_6_189_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.276311"},{"key":"e_1_3_6_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.niox.2017.07.005"},{"key":"e_1_3_6_191_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202107-864OC"},{"key":"e_1_3_6_192_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-03051-4"},{"key":"e_1_3_6_193_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.09.052"},{"issue":"67","key":"e_1_3_6_194_1","first-page":"A3909","article-title":"A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman Primates and human lung","volume":"62","author":"Yuan T","unstructured":"Yuan T, Klossowski S, Afrazi M, et al. A clinical-stage RNAi therapeutic candidate for IPF mediates durable MMP7 silencing in nonhuman Primates and human lung. Tissue. 62(suppl 67):A3909. https:\/\/publications.ersnet.org\/content\/erj\/62\/suppl67\/pa3909","journal-title":"Tissue"},{"key":"e_1_3_6_195_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050093"},{"key":"e_1_3_6_196_1","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2017.1300533"},{"key":"e_1_3_6_197_1","doi-asserted-by":"crossref","unstructured":"Yuan T Nicholas A Lakomski N et al. Silencing MMP7 expression with a lung-targeted RNAi molecule limits fibrosis and preserves pulmonary function in bleomycin-injured rats. 60(suppl 66):864. https:\/\/publications.ersnet.org\/content\/erj\/60\/suppl66\/864","DOI":"10.1183\/13993003.congress-2022.864"},{"key":"e_1_3_6_198_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002142"},{"key":"e_1_3_6_199_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00762-6"},{"key":"e_1_3_6_200_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/143.3_Pt_2.S43"},{"key":"e_1_3_6_201_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00218613"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2748249","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17425247.2026.2748249","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2026.2748249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:59:33Z","timestamp":1792051173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2026.2748249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":199,"alternative-id":["10.1080\/17425247.2026.2748249"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2026.2748249","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}